Full View

Carfilzomib treatment causes molecular and functional alterations of human induced pluripotent stem cell–derived cardiomyocytes

P Forghani, A Rashid, F Sun, R Liu, D Li… - Journal of the …, 2021 - Am Heart Assoc
Background Anticancer therapies have significantly improved patient outcomes; however,
cardiac side effects from cancer therapies remain a significant challenge. Cardiotoxicity …
被引用次数：18 相关文章
[PDF] researchgate.net

[PDF][PDF] Carfilzomib Treatment Causes Molecular and Functional Alterations of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes

P Forghani, A Rashid, F Sun, R Liu, D Li, MR Lee… - 2021 - researchgate.net
BACKGROUND: Anticancer therapies have significantly improved patient outcomes;
however, cardiac side effects from cancer therapies remain a significant challenge …

Carfilzomib Treatment Causes Molecular and Functional Alterations of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

P Forghani, A Rashid, F Sun, R Liu… - Journal of the …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Anticancer therapies have significantly improved patient outcomes; however,
cardiac side effects from cancer therapies remain a significant challenge. Cardiotoxicity …
[PDF] nsf.gov

[PDF][PDF] Carfilzomib Treatment Causes Molecular and Functional Alterations of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

P Forghani, A Rashid - Journal of the American Heart Association, 2021 - par.nsf.gov
Background ̶ Anticancer therapies have significantly improved patient outcomes; however,
cardiac side effects from cancer therapies remain a significant challenge. Cardiotoxicity …

Carfilzomib Treatment Causes Molecular and Functional Alterations of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

P Forghani, A Rashid, F Sun, R Liu, D Li… - Journal of the …, 2021 - europepmc.org
Background Anticancer therapies have significantly improved patient outcomes; however,
cardiac side effects from cancer therapies remain a significant challenge. Cardiotoxicity …
[PDF] salaitalab.com

[PDF][PDF] Carfilzomib Treatment Causes Molecular and Functional Alterations of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes

P Forghani, A Rashid, F Sun, R Liu, D Li, MR Lee… - 2021 - salaitalab.com
BACKGROUND: Anticancer therapies have significantly improved patient outcomes;
however, cardiac side effects from cancer therapies remain a significant challenge …
[HTML] nih.gov

[HTML][HTML] Carfilzomib Treatment Causes Molecular and Functional Alterations of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes

P Forghani, A Rashid, F Sun, R Liu, D Li… - Journal of the …, 2021 - ncbi.nlm.nih.gov
Background Anticancer therapies have significantly improved patient outcomes; however,
cardiac side effects from cancer therapies remain a significant challenge. Cardiotoxicity …

Carfilzomib Treatment Causes Molecular and Functional Alterations of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

P Forghani, A Rashid, F Sun, R Liu… - Journal of the …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Anticancer therapies have significantly improved patient outcomes; however,
cardiac side effects from cancer therapies remain a significant challenge. Cardiotoxicity …